The KRAS-pathway is known to be involved in cellular proliferation associated with colon, pancreatic, and lung cancer [58] and has previously been shown to have an influence on HIF1A translational regulation within hypoxia [59]. This evidence concerns the gene HIF1A and lung cancer.